Literature DB >> 7585576

Radiation-induced apoptosis: effects of cell age and dose fractionation.

C C Ling1, M Guo, C H Chen, T Deloherey.   

Abstract

The cell cycle dependence of radiation-induced apoptosis was measured using mitotically synchronized REC:myc(ch1) and Rat1:mycb cells. Cells in S and G2 phases were more susceptible; the apoptotic fraction was about 0.7-0.8 as compared to about 0.4 for G1 cells at a dose of 10 Gy. Two-dimensional cytofluorimetric analysis of cells, pulsed-labeled with bromodeoxyuridine and then irradiated with 10 Gy, showed both G1 and G2 blocks (6-8 h) for REC:myc(ch1) cells but only G2 block for Rat1:mycb cells. Consistent with these results, wild-type p53 and WAF1 (or p21), known to play a role in G1 delay, was induced by radiation in REC:myc(ch1) but not in Rat1:mycb cells. The cell cycle dependence of radiation-induced apoptosis and the absence of a G1 block for Rat1:mycb cells led to the prediction and observation of the novel "inverse split-dose effect," i.e., a radiation dose given in two equal halves separated by a few hours yielded a higher level of apoptosis relative to that resulting from the same total dose given all at once. This effect is due to cell cycle progression from G1 to the more sensitive S-G2 phase during the interval between the split doses. In contrast, the inverse split-dose effect for apoptosis is absent for REC:myc(ch1), due presumably to the radiation-induced G1 delay. Parallel split-dose experiments, but using clonogenic survival as end points, show recovery for REC:myc(ch1) cells but not for Rat1:mycb cells, reflecting the influence of split-dose, radiation-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585576

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

Authors:  I Herr; D Wilhelm; T Böhler; P Angel; K M Debatin
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

2.  The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene.

Authors:  L A Allan; T Duhig; M Read; M Fried
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines.

Authors:  Zsolt Fábián; Christine M Csatary; József Szeberényi; Laszlo K Csatary
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

Review 4.  Effects of histone acetylation and DNA methylation on p21( WAF1) regulation.

Authors:  Jing-Yuan Fang; You-Yong Lu
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 5.  An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response.

Authors:  Benjamin Titz; Robert Jeraj
Journal:  Phys Med Biol       Date:  2008-08-01       Impact factor: 3.609

6.  [Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas].

Authors:  A Tannapfel; S Nüsslein; A Katalinic; F Köckerling; C Wittekind; R Fietkau
Journal:  Strahlenther Onkol       Date:  1998-06       Impact factor: 3.621

7.  Prolonged expression of senescence markers in mice exposed to gamma-irradiation.

Authors:  Min-A Seol; Uhee Jung; Hyeon Soo Eom; Seol-Hwa Kim; Hae-Ran Park; Sung-Kee Jo
Journal:  J Vet Sci       Date:  2012-12       Impact factor: 1.672

8.  p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase/Akt/GSK3 signaling.

Authors:  G Nayak; G M Cooper
Journal:  Cell Death Dis       Date:  2012-10-11       Impact factor: 8.469

9.  Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.

Authors:  Seong Hyun Jeong; Hyun-Woo Lee; Jae Ho Han; Seok Yun Kang; Jin-Hyuk Choi; Youn Mu Jung; Ho Choi; Young Taek Oh; Kwang Joo Park; Sung Chul Hwang; Seung Soo Sheen; Yoon Jung Oh; Jang Hee Kim; Ho-Yeong Lim
Journal:  Jpn J Clin Oncol       Date:  2008-09-04       Impact factor: 3.019

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.